Cargando…
Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis
BACKGROUND: Patients with locally advanced esophageal or gastroesophageal adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant chemoradiation (nCRT), respectively, perioperative chemotherapy (pCT). However, it remains unclear which treatment is superior concerning postoperat...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016042/ https://www.ncbi.nlm.nih.gov/pubmed/34223965 http://dx.doi.org/10.1007/s00432-021-03720-5 |
_version_ | 1784688443836596224 |
---|---|
author | Plum, Patrick Sven Damanakis, Alexander Buschmann, Lisa Ernst, Angela Datta, Rabi Raj Schiffmann, Lars Mortimer Zander, Thomas Fuchs, Hans Chon, Seung-Hun Alakus, Hakan Schröder, Wolfgang Hölscher, Arnulf Heinrich Bruns, Christiane Josephine Bludau, Marc |
author_facet | Plum, Patrick Sven Damanakis, Alexander Buschmann, Lisa Ernst, Angela Datta, Rabi Raj Schiffmann, Lars Mortimer Zander, Thomas Fuchs, Hans Chon, Seung-Hun Alakus, Hakan Schröder, Wolfgang Hölscher, Arnulf Heinrich Bruns, Christiane Josephine Bludau, Marc |
author_sort | Plum, Patrick Sven |
collection | PubMed |
description | BACKGROUND: Patients with locally advanced esophageal or gastroesophageal adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant chemoradiation (nCRT), respectively, perioperative chemotherapy (pCT). However, it remains unclear which treatment is superior concerning postoperative morbidity. METHODS: In this study, we compared the postsurgical survival (30-day/90-day/1-year mortality) (primary endpoint), treatment response, and surgical complications (secondary endpoints) of patients who either received nCRT (CROSS protocol) or pCT (FLOT protocol) due to esophageal/gastroesophageal adenocarcinoma. Between January 2013 and December 2017, 873 patients underwent Ivor Lewis esophagectomy in our high-volume center. 339 patients received nCRT and 97 underwent pCT. After 1:1 propensity score matching (matching criteria: sex, age, BMI, ASA score, and Charlson score), 97 patients per subgroup were included for analysis. RESULTS: After matching, tumor response (ypT/ypN) did not differ significantly between nCRT and pCT (p = 0.118, respectively, p = 0.174). Residual nodal metastasis occurred more often after pCT (p = 0.001). Postsurgical mortality was comparable within both groups. No patient died within 30 or 90 days after surgery while the 1-year survival rate was 72.2% for nCRT and 68.0% for pCT (p = 0.47). Only grade 3a complications according to Clavien–Dindo were increased after pCT (p = 0.04). There was a trend towards a higher rate of pylorospasm within the pCT group (nCRT: 23.7% versus pCT: 37.1%) (p = 0.061). Multivariate analysis identified pCT, younger age, and Charlson score as independent variables for pylorospasm. CONCLUSION: Both nCRT and pCT are safe and efficient within the multimodal treatment of esophageal/gastroesophageal adenocarcinoma. We did not observe differences in postoperative morbidity. However, functional aspects such as gastric emptying might be more frequent after pCT. |
format | Online Article Text |
id | pubmed-9016042 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-90160422022-05-02 Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis Plum, Patrick Sven Damanakis, Alexander Buschmann, Lisa Ernst, Angela Datta, Rabi Raj Schiffmann, Lars Mortimer Zander, Thomas Fuchs, Hans Chon, Seung-Hun Alakus, Hakan Schröder, Wolfgang Hölscher, Arnulf Heinrich Bruns, Christiane Josephine Bludau, Marc J Cancer Res Clin Oncol Original Article – Clinical Oncology BACKGROUND: Patients with locally advanced esophageal or gastroesophageal adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant chemoradiation (nCRT), respectively, perioperative chemotherapy (pCT). However, it remains unclear which treatment is superior concerning postoperative morbidity. METHODS: In this study, we compared the postsurgical survival (30-day/90-day/1-year mortality) (primary endpoint), treatment response, and surgical complications (secondary endpoints) of patients who either received nCRT (CROSS protocol) or pCT (FLOT protocol) due to esophageal/gastroesophageal adenocarcinoma. Between January 2013 and December 2017, 873 patients underwent Ivor Lewis esophagectomy in our high-volume center. 339 patients received nCRT and 97 underwent pCT. After 1:1 propensity score matching (matching criteria: sex, age, BMI, ASA score, and Charlson score), 97 patients per subgroup were included for analysis. RESULTS: After matching, tumor response (ypT/ypN) did not differ significantly between nCRT and pCT (p = 0.118, respectively, p = 0.174). Residual nodal metastasis occurred more often after pCT (p = 0.001). Postsurgical mortality was comparable within both groups. No patient died within 30 or 90 days after surgery while the 1-year survival rate was 72.2% for nCRT and 68.0% for pCT (p = 0.47). Only grade 3a complications according to Clavien–Dindo were increased after pCT (p = 0.04). There was a trend towards a higher rate of pylorospasm within the pCT group (nCRT: 23.7% versus pCT: 37.1%) (p = 0.061). Multivariate analysis identified pCT, younger age, and Charlson score as independent variables for pylorospasm. CONCLUSION: Both nCRT and pCT are safe and efficient within the multimodal treatment of esophageal/gastroesophageal adenocarcinoma. We did not observe differences in postoperative morbidity. However, functional aspects such as gastric emptying might be more frequent after pCT. Springer Berlin Heidelberg 2021-07-05 2022 /pmc/articles/PMC9016042/ /pubmed/34223965 http://dx.doi.org/10.1007/s00432-021-03720-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article – Clinical Oncology Plum, Patrick Sven Damanakis, Alexander Buschmann, Lisa Ernst, Angela Datta, Rabi Raj Schiffmann, Lars Mortimer Zander, Thomas Fuchs, Hans Chon, Seung-Hun Alakus, Hakan Schröder, Wolfgang Hölscher, Arnulf Heinrich Bruns, Christiane Josephine Bludau, Marc Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis |
title | Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis
|
title_full | Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis
|
title_fullStr | Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis
|
title_full_unstemmed | Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis
|
title_short | Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis
|
title_sort | short-term outcome of ivor lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis |
topic | Original Article – Clinical Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016042/ https://www.ncbi.nlm.nih.gov/pubmed/34223965 http://dx.doi.org/10.1007/s00432-021-03720-5 |
work_keys_str_mv | AT plumpatricksven shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis AT damanakisalexander shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis AT buschmannlisa shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis AT ernstangela shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis AT dattarabiraj shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis AT schiffmannlarsmortimer shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis AT zanderthomas shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis AT fuchshans shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis AT chonseunghun shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis AT alakushakan shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis AT schroderwolfgang shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis AT holscherarnulfheinrich shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis AT brunschristianejosephine shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis AT bludaumarc shorttermoutcomeofivorlewisesophagectomyfollowingneoadjuvantchemoradiationversusperioperativechemotherapyinpatientswithlocallyadvancedadenocarcinomaoftheesophagusandgastroesophagealjunctionapropensityscorematchedanalysis |